128 related articles for article (PubMed ID: 9606029)
1. Central activation of the sympathetic nervous system including the adrenals in anaesthetized guinea pigs by the muscarinic agonist talsaclidine.
Walland A; Pieper MP
Naunyn Schmiedebergs Arch Pharmacol; 1998 Apr; 357(4):426-30. PubMed ID: 9606029
[TBL] [Abstract][Full Text] [Related]
2. Compensation of muscarinic bronchial effects of talsaclidine by concomitant sympathetic activation in guinea pigs.
Walland A; Palluk R; Burkard S; Hammer R
Eur J Pharmacol; 1997 Jul; 330(2-3):213-9. PubMed ID: 9253956
[TBL] [Abstract][Full Text] [Related]
3. In vivo consequences of M1-receptor activation by talsaclidine.
Walland A; Burkard S; Hammer R; Tröger W
Life Sci; 1997; 60(13-14):977-84. PubMed ID: 9121364
[TBL] [Abstract][Full Text] [Related]
4. Memory-related task performance by aged rhesus monkeys administered the muscarinic M(1)-preferring agonist, talsaclidine.
Terry AV; Buccafusco JJ; Borsini F; Leusch A
Psychopharmacology (Berl); 2002 Jul; 162(3):292-300. PubMed ID: 12122487
[TBL] [Abstract][Full Text] [Related]
5. Pharmacodynamic profile of the M1 agonist talsaclidine in animals and man.
Wienrich M; Meier D; Ensinger HA; Gaida W; Raschig A; Walland A; Hammer R
Life Sci; 2001 Apr; 68(22-23):2593-600. PubMed ID: 11392631
[TBL] [Abstract][Full Text] [Related]
6. Evidence for prejunctional inhibitory muscarinic receptors on sympathetic nerves innervating guinea-pig trachealis muscle.
Pendry YD; Maclagan J
Br J Pharmacol; 1991 May; 103(1):1165-71. PubMed ID: 1878754
[TBL] [Abstract][Full Text] [Related]
7. General pharmacological profile of the novel muscarinic receptor agonist SNI-2011, a drug for xerostomia in Sjögren's syndrome. 2nd communication: effects on somatic nervous system and on autonomic nervous system and smooth muscle.
Arisawa H; Fukui K; Fujise N; Masunaga H
Arzneimittelforschung; 2002; 52(2):81-8. PubMed ID: 11878203
[TBL] [Abstract][Full Text] [Related]
8. SB 202026: a novel muscarinic partial agonist with functional selectivity for M1 receptors.
Loudon JM; Bromidge SM; Brown F; Clark MS; Hatcher JP; Hawkins J; Riley GJ; Noy G; Orlek BS
J Pharmacol Exp Ther; 1997 Dec; 283(3):1059-68. PubMed ID: 9399977
[TBL] [Abstract][Full Text] [Related]
9. WAL 2014--a muscarinic agonist with preferential neuron-stimulating properties.
Ensinger HA; Doods HN; Immel-Sehr AR; Kuhn FJ; Lambrecht G; Mendla KD; Müller RE; Mutschler E; Sagrada A; Walther G
Life Sci; 1993; 52(5-6):473-80. PubMed ID: 8441328
[TBL] [Abstract][Full Text] [Related]
10. Evidence for prejunctional muscarinic autoreceptors in human and guinea pig trachea.
Patel HJ; Barnes PJ; Takahashi T; Tadjkarimi S; Yacoub MH; Belvisi MG
Am J Respir Crit Care Med; 1995 Sep; 152(3):872-8. PubMed ID: 7663798
[TBL] [Abstract][Full Text] [Related]
11. A comparison of the central and peripheral antimuscarinic effects of atropine and methylatropine injected systemically and into the cerebral ventricles.
Brezenoff HE; Xiao YF; Vargas H
Life Sci; 1988; 42(8):905-11. PubMed ID: 3343890
[TBL] [Abstract][Full Text] [Related]
12. Evidence for transmission through sympathetic ganglia mediated by muscarinic receptors in anesthetized guinea pigs.
Alsip NL; DiMicco JA
Neuropharmacology; 1986 May; 25(5):515-8. PubMed ID: 3016588
[TBL] [Abstract][Full Text] [Related]
13. Treatment with the selective muscarinic m1 agonist talsaclidine decreases cerebrospinal fluid levels of A beta 42 in patients with Alzheimer's disease.
Hock C; Maddalena A; Raschig A; Müller-Spahn F; Eschweiler G; Hager K; Heuser I; Hampel H; Müller-Thomsen T; Oertel W; Wienrich M; Signorell A; Gonzalez-Agosti C; Nitsch RM
Amyloid; 2003 Mar; 10(1):1-6. PubMed ID: 12762134
[TBL] [Abstract][Full Text] [Related]
14. Identification of M1 muscarinic receptors in pulmonary sympathetic nerves in the guinea-pig by use of pirenzepine.
Maclagan J; Fryer AD; Faulkner D
Br J Pharmacol; 1989 Jun; 97(2):499-505. PubMed ID: 2758228
[TBL] [Abstract][Full Text] [Related]
15. Effects of tachykinin NK1 receptor antagonists on vagal hyperreactivity and neuronal M2 muscarinic receptor function in antigen challenged guinea-pigs.
Costello RW; Fryer AD; Belmonte KE; Jacoby DB
Br J Pharmacol; 1998 May; 124(2):267-76. PubMed ID: 9641542
[TBL] [Abstract][Full Text] [Related]
16. [Effect of a muscarinic (M1) receptor agonist on sympathetic nerve activity in rats].
Saito Y
Hokkaido Igaku Zasshi; 1993 Mar; 68(2):190-204. PubMed ID: 8509063
[TBL] [Abstract][Full Text] [Related]
17. Effects of intracerebroventricular injected choline on cardiovascular functions and sympathoadrenal activity.
Arslan BY; Ulus IH; Savci V; Kiran BK
J Cardiovasc Pharmacol; 1991 May; 17(5):814-21. PubMed ID: 1713998
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological characterization of the muscarinic receptor antagonist, glycopyrrolate, in human and guinea-pig airways.
Haddad EB; Patel H; Keeling JE; Yacoub MH; Barnes PJ; Belvisi MG
Br J Pharmacol; 1999 May; 127(2):413-20. PubMed ID: 10385241
[TBL] [Abstract][Full Text] [Related]
19. Characterization of aclidinium bromide, a novel inhaled muscarinic antagonist, with long duration of action and a favorable pharmacological profile.
Gavaldà A; Miralpeix M; Ramos I; Otal R; Carreño C; Viñals M; Doménech T; Carcasona C; Reyes B; Vilella D; Gras J; Cortijo J; Morcillo E; Llenas J; Ryder H; Beleta J
J Pharmacol Exp Ther; 2009 Nov; 331(2):740-51. PubMed ID: 19710368
[TBL] [Abstract][Full Text] [Related]
20. Central muscarinic receptors signal pilocarpine-induced salivation.
Takakura AC; Moreira TS; Laitano SC; De Luca Júnior LA; Renzi A; Menani JV
J Dent Res; 2003 Dec; 82(12):993-7. PubMed ID: 14630901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
